NuMedii
Menlo Park
About NuMedii
NuMedii is a biotechnology company that discovers and de-risks effective new drugs by translating life sciences big data into therapies. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii. It utilizes hundreds of millions of raw human, biological, pharmacological, and clinical data points. The company was founded in 2008 and headquartered in San Mateo, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $5.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2015)
- Website: numedii.com
- Phone: 650-521-6363
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/numedii-139145 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.